# Santiago Pujadas, MBA

> Santiago Pujadas is co-CEO of Imagine Pharma and Zer0 to 5ive, based in Devon, Pennsylvania. His career includes leading CATCO and Wesdyne International, advising companies on communications, and community service including the American Friends of the National Museum of Bermuda. He holds undergraduate and graduate degrees from Carnegie Mellon University.

- **Role:** Co-CEO at Imagine Pharma
- **Organizations:** Imagine Pharma, Zer0 to 5ive, Wesdyne International (former president), CATCO (former president), American Friends of the National Museum of Bermuda, FLITE (board service), Suburban Seahawks Club (board service), Institute for Student Achievement (leadership committee service), Devon Horse Show
- **Education:** BS in Industrial Management and Mathematics, Carnegie Mellon University, MS in Industrial Administration, Carnegie Mellon University, Tepper School of Business
- **Known for:** CATCO attained over 90% market share in its segment under his leadership., Wesdyne grew to over $100 million in revenue under his leadership., Joint Volunteer of the Year recognition with his wife from the Devon Horse Show; official biographies say 2011, while LinkedIn lists 2012.

## Career timeline

- **—** — President of CATCO, a Westinghouse and Électricité de France software development joint venture, before leading Wesdyne.
- **—** — President of Wesdyne International, a Westinghouse subsidiary in robotics inspection, before Zer0 to 5ive.
- **—** — Became co-CEO of Zer0 to 5ive; exact joining date not verified.
- **2016** — Leadership of Imagine Pharma from its inception.
- **2023** — Imagine Pharma announced a $32.5 million Series A on October 31.

## Achievements

- CATCO attained over 90% market share in its segment under his leadership.
- Wesdyne grew to over $100 million in revenue under his leadership.
- Joint Volunteer of the Year recognition with his wife from the Devon Horse Show; official biographies say 2011, while LinkedIn lists 2012.
- Co-led Imagine Pharma when it announced a $32.5 million Series A in October 2023.

## Latest updates

- **2024-05** — Zer0 to 5ive, the agency he co-leads, marked its 25th anniversary with a team celebration in Devon.
- **2023-10** — Imagine Pharma announced a $32.5 million Series A, with an initial $10 million tranche and stated cumulative funding of $40 million.

## Links

- LinkedIn: https://www.linkedin.com/in/santiago-pujadas-659a14108

---

Profile page: https://yespress.io/santiago-pujadas
Published by YesPress — https://yespress.io
Last updated: 2026-10-13